Literature DB >> 2173251

Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases.

T Sano1, K Kovacs, S L Asa, H S Smyth.   

Abstract

Two pituitary adenomas removed from a 37-year-old woman and a 26-year-old woman with typical Cushing's disease were studied by light and electron microscopy, immunohistochemistry and radioimmunoassay of tissue culture media. Both patients had high plasma levels of cortisol and normal levels of luteinizing hormone (LH). Both tumours were monomorphous, composed of densely granulated corticotrophs; the tumour cells contained periodic acid-Schiff positivity, were arranged in a sinusoidal pattern and, ultrastructurally, contained well-developed cytoplasmic organelles. By immunohistochemistry the majority of tumour cells contained immunoreactive adrenocorticotropin (ACTH); approximately 10% of the tumour cell population contained LH immunoreactivity. The LH-positive cells tended to form clusters scattered widely throughout the tumour tissues. LH immunoreactivity was demonstrated in some ACTH-immunoreactive cells on serial sections. Large amounts of immunoreactive ACTH and smaller quantities of LH, follicle stimulating hormone and alpha-subunit were released into the culture media and release of the glycoprotein hormones responded in parallel to corticotropin releasing hormone stimulation or inhibition by cortisol. These findings indicate that LH can be simultaneously produced and released by ACTH-producing tumour cells of otherwise typical functioning corticotroph adenomas. The capacity for LH production may be acquired during neoplastic proliferation. This is the first detailed report of concurrent production of LH by pituitary corticotroph adenomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173251     DOI: 10.1007/BF01605790

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  18 in total

1.  Persistent lactation associated with pituitary tumor and hyperadrenal corticism; successfully treated with pituitary radiation.

Authors:  M E LEVIN; W H DAUGHADAY; I LEVY
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

2.  Cure of Cushing's disease by transsphenoidal removal of a microadenoma from a pituitary gland despite a radiographically normal sella turcica.

Authors:  S T Bigos; F Robert; G Pelletier; J Hardy
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

Review 3.  Fine structural cytology of the adenohypophysis in rat and man.

Authors:  E Horvath; K Kovacs
Journal:  J Electron Microsc Tech       Date:  1988-04

4.  Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas.

Authors:  S L Asa; B M Gerrie; W Singer; E Horvath; K Kovacs; H S Smyth
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Monomorphous plurihormonal adenoma of the human pituitary. A histologic, immunocytologic and ultrastructural study.

Authors:  D J McComb; T A Bayley; E Horvath; K Kovacs; I A Kourides
Journal:  Cancer       Date:  1984-04-01       Impact factor: 6.860

7.  Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.

Authors:  P Beck-Peccoz; G Piscitelli; S Amr; M Ballabio; M Bassetti; G Giannattasio; A Spada; M Nissim; B D Weintraub; G Faglia
Journal:  J Clin Endocrinol Metab       Date:  1986-04       Impact factor: 5.958

8.  Concurrent production of adrenocorticotropin and prolactin from two distinct cell lines in a single pituitary adenoma: a detailed immunohistochemical analysis.

Authors:  S H Sherry; A T Guay; A K Lee; E T Hedley Whyte; M Federman; S R Freidberg; P D Woolf
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

Review 9.  Pituitary gland.

Authors:  E Horvath; K Kovacs
Journal:  Pathol Res Pract       Date:  1988-04       Impact factor: 3.250

10.  Pituitary pathology in Cushing's disease.

Authors:  W Saeger; F Geisler; D K Lüdecke
Journal:  Pathol Res Pract       Date:  1988-09       Impact factor: 3.250

View more
  6 in total

1.  Silent corticotroph adenoma with multiple cysts: Pars intermedia tumor?

Authors:  Hiroshi Nishioka; Asao Hirano; Sylvia L Asa
Journal:  Endocr Pathol       Date:  1992-03       Impact factor: 3.943

2.  Plurihormonality in pituitary adenomas associated with acromegaly.

Authors:  Fateme Salehi; Sandra Cohen; Luis V Syro; Humberto Uribe; Eva Horvath; Kalman Kovacs; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 3.  Molecular determinants of pituitary cytodifferentiation.

Authors:  S L Asa; S Ezzat
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

4.  Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.

Authors:  Odelia Cooper; Anat Ben-Shlomo; Vivien Bonert; Serguei Bannykh; James Mirocha; Shlomo Melmed
Journal:  Horm Cancer       Date:  2010-04       Impact factor: 3.869

5.  ACTH and alpha-subunit are co-expressed in rare human pituitary corticotroph cell adenomas proposed to originate from ACTH-committed early pituitary progenitor cells.

Authors:  Masanori Suzuki; Noboru Egashira; Hanako Kajiya; Takeo Minematsu; Susumu Takekoshi; Shigeyuki Tahara; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

6.  Anatomy of a viral entry platform differentially functionalized by integrins α3 and α6.

Authors:  Jérôme Finke; Snježana Mikuličić; Anna-Lena Loster; Alexander Gawlitza; Luise Florin; Thorsten Lang
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.